Abstract
AIDS Research and Human RetrovirusesVol. 30, No. S1 T-Cell (CD4 & CD8) ResponsesT-cell Responses Targeting HIV Env V2 in Natural Infection: Implications for RV144 Vaccine RecipientsAndrew Gartland, John McNevin, Pradyot Dash, Paul Thomas, Tomer Hertz, and Julie McElrathAndrew GartlandFred Hutchinson Cancer Research Center, Vaccines and Infectious Disease, Seattle, WA, United StatesSearch for more papers by this author, John McNevinFred Hutchinson Cancer Research Center, Vaccines and Infectious Disease, Seattle, WA, United StatesSearch for more papers by this author, Pradyot DashSt. Jude Children's Research Hospital, Immunology, Memphis, TN, United StatesSearch for more papers by this author, Paul ThomasSt. Jude Children's Research Hospital, Immunology, Memphis, TN, United StatesSearch for more papers by this author, Tomer HertzFred Hutchinson Cancer Research Center, Vaccines and Infectious Disease, Seattle, WA, United StatesSearch for more papers by this author, and Julie McElrathFred Hutchinson Cancer Research Center, Vaccines and Infectious Disease, Seattle, WA, United StatesSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5381.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"T-cell Responses Targeting HIV Env V2 in Natural Infection: Implications for RV144 Vaccine Recipients." AIDS Research and Human Retroviruses, 30(S1), p. A179FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Andrew Gartland, John McNevin, Pradyot Dash, Paul Thomas, Tomer Hertz, and Julie McElrath.T-cell Responses Targeting HIV Env V2 in Natural Infection: Implications for RV144 Vaccine Recipients.AIDS Research and Human Retroviruses.Oct 2014.A179-A179.http://doi.org/10.1089/aid.2014.5381.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
